Atara Biotherapeutics (ATRA) Other financing activities (2013 - 2023)
Atara Biotherapeutics (ATRA) reported Other financing activities of -$13000.0 for Q2 2023, down 100.04% quarter-over-quarter from $30.8 million in Q4 2022.
Atara Biotherapeutics (ATRA) Other financing activities (2013 - 2023) Analysis & Trends
Atara Biotherapeutics has reported Other financing activities for 6 years, with the latest figure at -$13000.0 in Q2 2023.
- For the quarter ending Q2 2023, Other financing activities changed N/A year-over-year to -$13000.0; the trailing twelve-month figure through Sep 2024 stood at -$13000.0 (down 100.04% YoY), and the FY2025 full-year result was -$1000.0, up 85.71% from the prior year.
- Other financing activities for Q2 2023 stood at -$13000.0, down from $30.8 million in the prior quarter.
- The five-year high for Other financing activities was $30.8 million in Q4 2022, with the low at -$165000.0 in Q1 2020.
- Historically, Other financing activities has averaged $4.4 million across 4 years, with a median of -$17000.0 in 2021.
- Annual changes were most pronounced in 2021 — Other financing activities soared 89.7% — and 2022, when it plunged 511.76%.
- Atara Biotherapeutics' Other financing activities stood at $165000.0 in 2020, then slumped by 110.3% to -$17000.0 in 2021, then jumped by 181041.18% to $30.8 million in 2022, then tumbled by 100.04% to -$13000.0 in 2023.
- The last three Other financing activities figures came in at -$13000.0 (Q2 2023), $30.8 million (Q4 2022), and -$51000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -13,000.00 |
| Dec 31, 2022 | 30.76 Mn |
| Dec 31, 2022 | 30.76 Mn |
| Sep 30, 2022 | -51,000.00 |
| Sep 30, 2022 | -51,000.00 |
| Mar 31, 2022 | -104,000.00 |
| Mar 31, 2022 | -104,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Dec 31, 2020 | 165,000.00 |
| Dec 31, 2020 | 165,000.00 |
| Mar 31, 2020 | -165,000.00 |
| Mar 31, 2020 | -165,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Sep 30, 2014 | -1.06 Mn |
| Sep 30, 2014 | -1.06 Mn |
| Jun 30, 2014 | 1.04 Mn |
| Jun 30, 2014 | 1.04 Mn |